Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer.

Anticancer research - 1 Jan 2000

Jager J J, Jansen R L, Arends J W, Joosten-Achjanie S, Volovics L, Schouten L J, De Jong J M, Meyenfeldt M F, Blijham G H

Abstract excerpt

PURPOSE: Tumor stage and nodal status are the most important factors predicting locoregional recurrence in breast cancer. We wanted to investigate the prognostic value of some newer molecular genetic markers for the occurrence of a locoregional recurrence, in order to improve the selection of patients for locoregional adjuvant therapy. METHODS: Bcl-2, p53, MIB-1, pS2 and CD44v6 were determined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Nuclear
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Hyaluronan Receptors

Share to Ki-67 Antigen

Share to Ploidies

Share to Proto-Oncogene Proteins c-bcl-2

Share to S Phase

Source

Identifiers

PMID: 10810433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer.PMID 10810433Read ↗

c-myc, p53 andbcl-2, apoptosis-related genes in infiltrating breast carcinomas: Evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patientsSemantic proximity Read ↗

Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.Semantic proximity Read ↗

Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.Semantic proximity Read ↗

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.Semantic proximity Read ↗

Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biologySemantic proximity Read ↗

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.Semantic proximity Read ↗

Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.Semantic proximity Read ↗

The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.Semantic proximity Read ↗

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.Semantic proximity Read ↗

The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis.Semantic proximity Read ↗

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.Semantic proximity Read ↗

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.